Navigation Links
Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production

WILMINGTON, Del., April 19, 2012 /PRNewswire/ -- Butamax™ Advanced Biofuels, LLC, a joint venture between BP and DuPont, announced today that it has entered into collaboration with Fagen, Inc. for the introduction of commercial biobutanol production using Butamax™ technology. Fagen is the world's most experienced biofuels engineering, procurement and construction contractor, having built more ethanol capacity than any other company.  They are the largest, most respected green energy design builder in the U.S. and have constructed over 85 ethanol plants totaling approximately 6 billion gallons of annual production. Fagen's extensive experience with ethanol production facilities and Butamax's pioneering biobutanol technology provides strong synergy for the rapid scale-up of biobutanol production.

(Logo: )

(Logo: )

"We are delighted to partner with Fagen on our path to commercialize biobutanol," said Paul Beckwith, Butamax CEO. "Fagen is simply the world leader when it comes to project execution in the biofuels industry, with leading standards for safety and quality. Our shared commitment to renewable energy makes Fagen a natural partner for Butamax and our shareholders."

"Butamax offers an exciting opportunity for ethanol facilities to leverage their existing assets to produce the next generation biofuel," said Aaron Fagen, CEO Fagen, Inc., "We look forward to working with Butamax in the deployment of their commercial strategy and their first retrofit project starting in 2013." 

Butamax was the first company to identify the opportunities and technology for cost-effective production of isobutanol through advanced biotechnology.  The company announced last December the formation of the Early Adopters Group (EAG), a consortium of world-class biofuel production companies interested in becoming early adopters of Butamax™ biobutanol technology. In addition, piloting work continues at the Butamax Technology Demonstration facility as the company prepares for market entry with commercial production in 2014.

About Butamax

Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont's proven industrial biotechnology experience and BP's global fuels market knowledge. Butamax's proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information about Butamax, visit

About Fagen

Fagen, Inc. is a full service industrial contractor and the largest green energy design-builder in the U.S. Utilizing a database of over 25,000 highly skilled craftworkers, Fagen, Inc. has constructed 60% of the ethanol production capacity in the United States, as well as multiple wind, solar, and power projects. The unmatched standard for safety, quality, and service has led Fagen, Inc. to be consistently listed in the Top 400 Contractors by Engineering News Record. For more information about Fagen, visit

Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.

Butamax Contact: Pam Schools


Fagen, Inc. Contact: Becky Dahl


SOURCE Butamax Advanced Biofuels, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Butamax™ Responds to Gevo Patent Infringement Lawsuit
2. Goodwin Biotechnology and RAFAGEN Announce a Collaboration
3. Medivir Announces TMC435 in an Expanded Clinical Collaboration
4. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
5. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
6. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
7. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
8. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
9. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
10. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
11. ADVENTRX Announces Establishment of Regulatory Advisory Board
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):